Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoutaro Tsuji

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Diagnostic Cytopathology|May 23, 2020
HEG1, BAP1, and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusionKenzo Hiroshima, Di Wu, Shinji Hamakawa, et al.
Pathology International|July 9, 2021
Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomasKenzo Hiroshima, Di Wu, Eitetsu Koh, et al.
International Journal of Cancer|January 12, 2024
Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1Taku Kouro, Naoko Higashijima, Shun Horaguchi, et al.
Circulation|December 15, 2023
HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial CellsIan A Tamargo, Kyung In Baek, Chenbo Xu, et al.
Scientific Reports|April 1, 2017
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesotheliomaShoutaro Tsuji, Kota Washimi, Taihei Kageyama, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Diagnostic Cytopathology|May 23, 2020
HEG1, BAP1, and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusionKenzo Hiroshima, Di Wu, Shinji Hamakawa, et al.
Pathology International|July 9, 2021
Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomasKenzo Hiroshima, Di Wu, Eitetsu Koh, et al.
International Journal of Cancer|January 12, 2024
Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1Taku Kouro, Naoko Higashijima, Shun Horaguchi, et al.
Circulation|December 15, 2023
HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial CellsIan A Tamargo, Kyung In Baek, Chenbo Xu, et al.
Scientific Reports|April 1, 2017
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesotheliomaShoutaro Tsuji, Kota Washimi, Taihei Kageyama, et al.
Pageof 5